PD-1/CD8 ratio was greater in NEC than in non-NEC components in 13 cases (42.4%), and the Foxp3/CD8 ratio was greater in NEC than in non-NEC components in 19 (57.6%) cases, as summarized in Table 3. The gene discussed is CD8A; the disease is neuroendocrine carcinoma.